Snapshot

The Emergency Use Authorization for Vaccines to Prevent COVID-19 pathway has been developed by the US Food and Drug Administration of United States.

This pathway can be used where COVID-19 vaccines..

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

Variable.